BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18855764)

  • 1. Determination and validation of off-target activities of anti-CD44 variant 6 antibodies using protein biochips and tissue microarrays.
    Lueking A; Beator J; Patz E; Müllner S; Mehes G; Amersdorfer P
    Biotechniques; 2008 Oct; 45(4):Pi-v. PubMed ID: 18855764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of affinity reagents using antigen microarrays.
    Sjöberg R; Sundberg M; Gundberg A; Sivertsson A; Schwenk JM; Uhlén M; Nilsson P
    N Biotechnol; 2012 Jun; 29(5):555-63. PubMed ID: 22134247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid characterization of binding specificity and cross-reactivity of antibodies using recombinant human protein arrays.
    Kijanka G; Ipcho S; Baars S; Chen H; Hadley K; Beveridge A; Gould E; Murphy D
    J Immunol Methods; 2009 Jan; 340(2):132-7. PubMed ID: 18996391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using protein microarrays to study cancer.
    Sreekumar A; Chinnaiyan AM
    Biotechniques; 2002 Dec; Suppl():46-53. PubMed ID: 12514929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells.
    Belov L; Huang P; Chrisp JS; Mulligan SP; Christopherson RI
    J Immunol Methods; 2005 Oct; 305(1):10-9. PubMed ID: 16125720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein microarrays for antibody profiling: specificity and affinity determination on a chip.
    Poetz O; Ostendorp R; Brocks B; Schwenk JM; Stoll D; Joos TO; Templin MF
    Proteomics; 2005 Jun; 5(9):2402-11. PubMed ID: 15887189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein biochips: the calm before the storm.
    Bodovitz S; Joos T; Bachmann J
    Drug Discov Today; 2005 Feb; 10(4):283-7. PubMed ID: 15708747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The applicability of a cluster of differentiation monoclonal antibody microarray to the diagnosis of human disease.
    Ellmark P; Woolfson A; Belov L; Christopherson RI
    Methods Mol Biol; 2008; 439():199-209. PubMed ID: 18370105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel kinetic analysis and affinity determination of hundreds of monoclonal antibodies using the ProteOn XPR36.
    Nahshol O; Bronner V; Notcovich A; Rubrecht L; Laune D; Bravman T
    Anal Biochem; 2008 Dec; 383(1):52-60. PubMed ID: 18782554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule selectivity and specificity profiling using functional protein microarrays.
    Kraus PR; Meng L; Freeman-Cook L
    Methods Mol Biol; 2010; 632():251-67. PubMed ID: 20217583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2.
    Stamnaes J; Fleckenstein B; Lund-Johansen F; Sollid LM
    Scand J Immunol; 2008 Nov; 68(5):534-42. PubMed ID: 18803608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic comparison of surface coatings for protein microarrays.
    Guilleaume B; Buness A; Schmidt C; Klimek F; Moldenhauer G; Huber W; Arlt D; Korf U; Wiemann S; Poustka A
    Proteomics; 2005 Dec; 5(18):4705-12. PubMed ID: 16267812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chip-based miniaturized format for protein-expression profiling: the exploitation of comprehensively produced antibodies.
    Koga H; Kyo M; Usui-Aoki K; Inamori K
    Electrophoresis; 2006 Sep; 27(18):3676-83. PubMed ID: 16915563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling.
    Nilsson P; Paavilainen L; Larsson K; Odling J; Sundberg M; Andersson AC; Kampf C; Persson A; Al-Khalili Szigyarto C; Ottosson J; Björling E; Hober S; Wernérus H; Wester K; Pontén F; Uhlen M
    Proteomics; 2005 Nov; 5(17):4327-37. PubMed ID: 16237735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody selection for interleukin-4 quantification using suspension arrays and forward-phase protein microarrays.
    Wang L; Cole KD; Peterson A; He HJ; Gaigalas AK; Zong Y
    J Proteome Res; 2007 Dec; 6(12):4720-7. PubMed ID: 17997516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of viruses using electrical biochips and anti-virion sera.
    Łoś M; Łoś JM; Blohm L; Spillner E; Grunwald T; Albers J; Hintsche R; Wegrzyn G
    Lett Appl Microbiol; 2005; 40(6):479-85. PubMed ID: 15892746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer.
    Pirnia F; Pawlak M; Thallinger GG; Gierke B; Templin MF; Kappeler A; Betticher DC; Gloor B; Borner MM
    Proteomics; 2009 Jul; 9(13):3535-48. PubMed ID: 19609961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody arrays for determination of relative protein abundances.
    Chaga GS
    Methods Mol Biol; 2008; 441():129-51. PubMed ID: 18370316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical characterization of SGN-70, a humanized antibody directed against CD70.
    McEarchern JA; Smith LM; McDonagh CF; Klussman K; Gordon KA; Morris-Tilden CA; Duniho S; Ryan M; Boursalian TE; Carter PJ; Grewal IS; Law CL
    Clin Cancer Res; 2008 Dec; 14(23):7763-72. PubMed ID: 19047103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.